HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PRDX6
peroxiredoxin 6
Chromosome 1 · 1q25.1
NCBI Gene: 9588Ensembl: ENSG00000117592.10HGNC: HGNC:16753UniProt: P30041
300PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
RESEARCH IMPACT
Trending
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
nucleusGO:0005615A2-type glycerophospholipase activityprotein bindingsystemic lupus erythematosusrheumatoid arthritisplacental retentiontricuspid valve disease
✦AI Summary

PRDX6 is a multifunctional thiol-specific peroxidase that catalyzes reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively, providing cellular protection against oxidative stress 1. Beyond its canonical peroxidase activity, PRDX6 exhibits phospholipase A2 (iPLA2) activity and acyl-CoA-dependent lysophospholipid acyltransferase activity, enabling both reduction and remodeling of phospholipids 12. Mechanistically, PRDX6 acts as a selenium-acceptor protein facilitating intracellular selenium utilization and selenoprotein incorporation, including ferroptosis-protective glutathione peroxidase 4 (GPX4) 3. This selenium-delivery function occurs through interaction with selenophosphate synthetase 2 (SEPHS2), representing an alternative selenocysteine metabolism pathway 4. Genetically, PRDX6-AS1 variants associate with systemic lupus erythematosus susceptibility, with elevated PRDX6 expression in patient immune cells 5. Functionally, PRDX6-iPLA2 activity regulates neuroinflammation post-ischemic stroke via ROS generation and astrocyte-microglia crosstalk 6, while PRDX6 inhibition by apigenin suppresses senescence-associated secretory phenotype development 7. In cancer, PRDX6 mediates ferroptosis resistance through NRF2-dependent mechanisms 8 and mitophagy inhibition in non-alcoholic steatohepatitis 9.

Sources cited
1
PRDX6 is a multifunctional thiol-specific peroxidase that catalyzes reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively, providing cellular protection against oxidative stress .
PMID: 10893423
2
Mechanistically, PRDX6 acts as a selenium-acceptor protein facilitating intracellular selenium utilization and selenoprotein incorporation, including ferroptosis-protective glutathione peroxidase 4 (GPX4) .
PMID: 39547222
3
This selenium-delivery function occurs through interaction with selenophosphate synthetase 2 (SEPHS2), representing an alternative selenocysteine metabolism pathway .
PMID: 39547224
4
Genetically, PRDX6-AS1 variants associate with systemic lupus erythematosus susceptibility, with elevated PRDX6 expression in patient immune cells .
PMID: 36311744
5
Functionally, PRDX6-iPLA2 activity regulates neuroinflammation post-ischemic stroke via ROS generation and astrocyte-microglia crosstalk , while PRDX6 inhibition by apigenin suppresses senescence-associated secretory phenotype development .
PMID: 38287382
6
Functionally, PRDX6-iPLA2 activity regulates neuroinflammation post-ischemic stroke via ROS generation and astrocyte-microglia crosstalk , while PRDX6 inhibition by apigenin suppresses senescence-associated secretory phenotype development .
PMID: 40265973
7
In cancer, PRDX6 mediates ferroptosis resistance through NRF2-dependent mechanisms and mitophagy inhibition in non-alcoholic steatohepatitis .
PMID: 38354236
8
In cancer, PRDX6 mediates ferroptosis resistance through NRF2-dependent mechanisms and mitophagy inhibition in non-alcoholic steatohepatitis .
PMID: 37040844
Disease Associationsⓘ20
systemic lupus erythematosusOpen Targets
0.34Weak
rheumatoid arthritisOpen Targets
0.30Weak
placental retentionOpen Targets
0.23Weak
tricuspid valve diseaseOpen Targets
0.21Weak
COVID-19Open Targets
0.19Weak
systemic sclerodermaOpen Targets
0.19Weak
type 2 diabetes mellitusOpen Targets
0.14Weak
non-alcoholic fatty liver diseaseOpen Targets
0.14Weak
Abnormality of the skeletal systemOpen Targets
0.11Weak
Alzheimer diseaseOpen Targets
0.10Suggestive
neoplasmOpen Targets
0.10Suggestive
ovarian cancerOpen Targets
0.09Suggestive
cancerOpen Targets
0.09Suggestive
lung adenocarcinomaOpen Targets
0.08Suggestive
intrahepatic cholangiocarcinomaOpen Targets
0.08Suggestive
Miyoshi myopathyOpen Targets
0.08Suggestive
esophageal squamous cell carcinomaOpen Targets
0.08Suggestive
non-small cell lung carcinomaOpen Targets
0.08Suggestive
cervical cancerOpen Targets
0.08Suggestive
diffuse large B-cell lymphomaOpen Targets
0.08Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
GPIProtein interaction100%ENO1Protein interaction100%GGT7Protein interaction96%GSTM1Protein interaction96%GSTP1Protein interaction96%TXNProtein interaction96%
Tissue Expression6 tissues
Liver
100%
Heart
63%
Lung
56%
Brain
43%
Ovary
36%
Bone Marrow
27%
Gene Interaction Network
Click a node to explore
PRDX6GPIENO1GGT7GSTM1GSTP1TXN
PROTEIN STRUCTURE
Preparing viewer…
PDB1PRX · 2.00 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.98LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.62 [0.40–0.98]
RankingsWhere PRDX6 stands among ~20K protein-coding genes
  • #1,169of 20,598
    Most Researched300 · top 10%
  • #9,338of 17,882
    Most Constrained (LOEUF)0.98
Genes detectedPRDX6
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1.
PMID: 36732502
Signal Transduct Target Ther · 2023
1.00
2
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance.
PMID: 39547224
Mol Cell · 2024
0.90
3
PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization.
PMID: 39547222
Mol Cell · 2024
0.80
4
PMID: 36311744
Front Immunol · 2022
0.70
5
Targeting PRDX6-dependent localization and function of GPX4 enhances ferroptosis-mediated tumor suppression.
PMID: 41418756
Mol Cell · 2025
0.64